THE CLINICAL SIGNIFICANCE OF CYTOMEGALOVIRAL INCLUSIONS IN THE ALLOGRAFT KIDNEY
Authors:
- Ron ShapiroRSRon Shapiro
- Mark JordanMJMark Jordan
- Parmjeet S. RandhawaPRParmjeet S. Randhawa
- 1 January 1999
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 67 (1) , 98-103
Abstract
Renal allografts are a frequent site of subclinical cytomegalovirus (CMV) infection diagnosed by culture, but histologic inclusions occur in less than 1% of biopsies. The natural history of this subgroup of patients has been reported only occasionally, mostly before the availability of ganciclovir therapy. We analyzed the clinical parameters and pathologic findings in 10 patients with CMV inclusions at allograft biopsy. The patients were 29-72 years old, and 9 of 10 (90%) had previous episodes of acute rejection, 3 of whom needed OKT3 administration. Histopathologic examination of the allografts showed interstitial inflammation with tubulitis in 7 of 10 (70%) patients; in 3 of 10 (30%) patients, viral inclusions were present in the glomerular capillary endothelia without any associated inflammatory response. Morphologic criteria for acute transplant glomerulopathy or proliferative glomerulonephritis were not satisfied. Extrarenal viral inclusions were documented in the gastrointestinal tracts of 2 of 10 (20%) patients. The patients were treated with reduced immunosuppression and ganciclovir. Five patients lost their grafts 56.6±86.6 days (range, 4-210 days; median, 21 days) after initial diagnosis. The serum creatinine in the remaining five patients was 3.3±2.0 mg/dl (range, 1.2-6.5 mg/dl; median, 2.5 mg/dl) 77±16 days (range, 56-101 days; median, 77 days) after transplantation. Histopathologic examination showed no residual viral inclusions in 5 of 7 (71.4%) follow-up specimens available for examination. CMV inclusions in renal allograft biopsies typically occur after treatment for rejection. Ganciclovir eradicates replicative virus, but graft outcome is determined by coexisting acute rejection and chronic allograft nephropathy. Graft loss primarily attributable to CMV was not observed.Keywords
This publication has 21 references indexed in Scilit:
- ISCHEMIC COLITIS SECONDARY TO VENOUS THROMBOSISTransplantation, 1996
- IN VITRO INDUCTION OF ENDOTHELIAL HLA CLASS II ANTIGEN EXPRESSION BY CYTOMEGALOVIRUS-ACTIVATED CD4+ T CELLS1Transplantation, 1993
- THE PROGNOSTIC SIGNIFICANCE OF POSITIVE CMV CULTURES DURING SURVEILLANCE OF RENAL TRANSPLANT RECIPIENTSTransplantation, 1993
- THE LONG PERSISTENCE OF CMV DNA IN THE BLOOD OF RENAL TRANSPLANT PATIENTS AFTER RECOVERY FROM CMV INFECTIONTransplantation, 1993
- CYTOMEGALOVIRUS INFECTION—AN ETIOLOGICAL FACTOR FOR REJECTION? A PROSPECTIVE STUDY IN 242 RENAL TRANSPLANT PATIENTSTransplantation, 1993
- FACTORS AFFECTING THE TEN-YEAR OUTCOME OF HUMAN RENAL ALLOGRAFTS: THE EFFECT OF VIRAL INFECTIONSTransplantation, 1991
- Cytomegalovirus-Associated Tubulointerstitial Nephritis in an Allogeneic Bone Marrow Transplant RecipientAnnals of Internal Medicine, 1987
- Demonstration by Light Microscopy of Cytomegalovirus on a Renal Biopsy of a Renal Allograft Recipient: Confirmation by Immunohistochemistry and in situ HybridizationNephron, 1987
- The histopathologic identification of CMV infected cells in biopsies of human renal allografts: An evaluation of 100 transplant biopsies by in situ hybridizationPathology - Research and Practice, 1986
- EFFECTS OF ANTITHYMOCYTE GLOBULIN ON CYTOMEGALOVIRUS INFECTION IN RENAL TRANSPLANT RECIPIENTSTransplantation, 1981